v3.26.3
Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (8,218,509) $ (9,466,966)
Adjustments to reconcile net loss to net cash used in operating activities    
Preferred shares issued as compensation 49,619 60,722
Common shares issued as compensation and for services 317,833 162,625
Warrants granted to Scientific Advisory Board 503 679
Depreciation 517,016 735,536
Amortization 8,270 8,269
Changes in operating assets and liabilities:    
Prepaid expenses (256,367) 60,596
Other assets 1,415 12,117
Accounts payable (135,278) 82,824
Accounts payable - related parties 7,121 101,417
Accrued expenses 12,362 (236,498)
NET CASH USED IN OPERATING ACTIVITIES (7,696,015) (8,478,679)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (84,317) (56,964)
NET CASH USED IN INVESTING ACTIVITIES (84,317) (56,964)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock 1,909,121 5,296,429
Net proceeds from the sale of common stock and common stock warrants 7,106,757  
NET CASH PROVIDED BY FINANCING ACTIVITIES 9,015,878 5,296,429
NET CHANGE IN CASH AND CASH EQUIVALENTS 1,235,546 (3,239,214)
Cash and cash equivalents at beginning of period 1,558,564 4,797,778
Cash and cash equivalents at end of period $ 2,794,110 1,558,564
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
Interest paid   $ 149